Mutual Funds Blogs Videos

No results found

did not match any result. Please try again.

Clear Search BackGround
Need Help?
0

SBI International Access vs Edelweiss US Value Equity Offshore Fund compare

Link copied to clipboard!

tortoise-icon SBI US Specific Equity Active FoF - Regular Plan - Growth

Invest Now

tortoise-icon Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option

Invest Now

Chart Comparison

Overview Trailing Returns SIP Returns Rolling Returns Risk Managers Market Cap Sectors

Overview

Scheme Name SBI US Specific Equity Active FoF - Regular Plan - Growth Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
Fund SBI US Specific Equity Active FoF - Regular Plan - Growth Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
Investment Plan Growth Growth
Level of Risk Average Very High
Asset Size (Cr) ₹1061 Cr ₹182 Cr
Min Investment ₹5000 ₹100
Min SIP Invesment ₹500 ₹100
Min Addl Investment ₹1000 ₹100
Launch Date 22 Mar 2021 07 Aug 2013
Category Gold Gold
Fund Type Open Ended Open Ended
Benchmark BSE 500 BSE India Bond Index
Turn Over 37% 18%
Expense Ratio 1.6 2.33
Manager Pradeep Kesavan Bhavesh Jain
ISIN Code INF200KA1T96 INF843K01ED9
Exits Load SBI International Access - US Equity FOF - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 365 days. There are no other charges./365 Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 90 days. There are no other charges./365

Trailing Lumpsum Returns

Scheme Name SBI US Specific Equity Active FoF - Regular Plan - Growth Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
1 Month 1.21% -0.39%
6 Month 30.82% 14.17%
1 Year 18.03% 5.71%
3 Year 24.95% 11.93%
5 Year - 14.48%

SIP Return Analysis

Scheme Name SBI US Specific Equity Active FoF - Regular Plan - Growth Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
6 Month 8.29% 4.8%
1 Year 38.92% 15.03%
3 Year 26.07% 13.42%
5 Year - 11.91%

Rolling Lumpsum Returns

Scheme Name SBI US Specific Equity Active FoF - Regular Plan - Growth Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
1 Year 14.25% 9.08%
3 Year 12.97% 9.77%
5 Year - 11.4%

Risk Management

Scheme Name SBI US Specific Equity Active FoF - Regular Plan - Growth Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
Standard Deviation 14.75% 12.43%
Sharp 1.17% 0.44%
Beta 1.09% 0.77%
Alpha -1.52% -7.59%

Fund Managers

Scheme Name SBI US Specific Equity Active FoF - Regular Plan - Growth Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option
Name Pradeep Kesavan Bhavesh Jain
Total AUM ₹434274 Cr ₹0 Cr
Funds Managed 43 22
SBI US Specific Equity Active FoF - Regular Plan - Growth Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option

Market Cap

Scheme Name

SBI US Specific Equity Active FoF - Regular Plan - Growth

Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option

Others 100 100

Sector Allocation

Scheme Name

SBI US Specific Equity Active FoF - Regular Plan - Growth

Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option

Others 100 100

Top Comparisons

Sundaram Aggressive Hybrid Fund (Formerly Known as Principal Hybrid Equity Fund)-Growth Sundaram Aggressive Hybrid Fund (Formerly Known as Principal Hybrid Equity Fund)-Growth

3Y Returns12.11%

VS

INVESCO INDIA AGGRESSIVE HYBRID FUND - Regular Plan - Growth INVESCO INDIA AGGRESSIVE HYBRID FUND - Regular Plan - Growth

3Y Returns15.41%

Compare Now

Kotak US Specific Equity Passive FOF - Regular Plan - Growth Kotak US Specific Equity Passive FOF - Regular Plan - Growth

3Y Returns34.55%

VS

Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option Edelweiss US Value Equity Offshore Fund - Regular Plan - Growth Option

3Y Returns11.93%

Compare Now

Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth Aditya Birla Sun Life Pharma and Healthcare Fund-Regular-Growth

3Y Returns20.44%

VS

Tata India Pharma & Healthcare Fund-Regular Plan-Growth Tata India Pharma & Healthcare Fund-Regular Plan-Growth

3Y Returns21.45%

Compare Now

Franklin U.S. Opportunities Equity Active FOF - Regular - Growth Franklin U.S. Opportunities Equity Active FOF - Regular - Growth

3Y Returns25.3%

VS

Sundaram Global Brand Theme - Equity Active FOF Regular Growth Sundaram Global Brand Theme - Equity Active FOF Regular Growth

3Y Returns22.27%

Compare Now
Add to Cart Successfully